Novel and Emerging Therapies for Inflammatory Bowel Disease

Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn’s disease are chronic, relapsing and remitting disorders of intestinal inflammation with potential systemic manifestations. Despite the availability of current biologics, such as anti-tumor necrosis factor (anti-TNF), anti-integr...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Bawardy, Badr, Shivashankar, Raina, Proctor, Deborah D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080036/
https://www.ncbi.nlm.nih.gov/pubmed/33935763
http://dx.doi.org/10.3389/fphar.2021.651415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080036/
https://www.ncbi.nlm.nih.gov/pubmed/33935763
http://dx.doi.org/10.3389/fphar.2021.651415

Ejemplares similares